Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remington Pharmaceutical Industries is a prominent Pakistani pharmaceutical company specializing in the development, manufacturing, and marketing of a diverse range of generic and branded generic medicines. Established in 1981, the company has grown into one of the largest ophthalmic product manufacturers in the region, with specialized facilities for sterile eye drops and ointments. Beyond ophthalmology, Remington maintains a significant portfolio in respiratory, anti-infective, and cardiovascular therapeutic areas. The company operates state-of-the-art, cGMP-compliant manufacturing units and exports its products to various international markets. It is recognized for its commitment to quality and its role in providing affordable healthcare solutions in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remington Pharmaceutical Industries.